Downregulation of TNF receptor-associated protein-2/p97 in renal cell carcinoma

Oncology Research

Volumn 11, Issue 2, 1999, Pages 85-90

  Stassar, Marike J J G ^a   Pitzer, Claudia ^a   Zöller, Margot ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Differential display; Differential expression; Low molecular weight proteins; Renal cell carcinoma; TRAP 2; Tumor associated antigens

Indexed keywords

BTAF1 PROTEIN, HUMAN; PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR IID;

ARTICLE; CELL CULTURE; DOWN REGULATION; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM;

CARCINOMA, RENAL CELL; DOWN-REGULATION; HUMANS; KIDNEY; KIDNEY NEOPLASMS; PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANSCRIPTION FACTOR TFIID; TUMOR CELLS, CULTURED;

EID: 0032603917     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Oliver, R. T.; Nethersell, A. B.; Bottomly, J. M. Unexplained spontaneous regression and alpha interferon as treatment for metastatic renal carcinoma. Br. J. Urol. 63:128-131; 1989.
2. De Riese, W.; Allhof, E.; Kirchne, H.; Stief, C. G.; Atzpodien, J.; Masckek, H.; Jonas, U. Complete spontaneous regression in metastatic renal cell carcinoma - an update and review. World J. Urol. 9:184-191; 1991.
3. Abubakr, Y. A.; Chou, T. H.; Redman, B. G. Spontaneous remission of renal cell carcinoma: A case report and immunological correlates. J. Urol. 152:156-157; 1994.
4. Bachl, C. M.; Riley, L. B.; Bae, Y. L.; Salmeron, M. A.; Platsoucas, C. D.; von Eschenbach, A.; Itoh, K. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch. Surg. 125: 200-205; 1990.
5. Belldegrun, A.; Pierce, W.; Kaboo, R.; Tso, C. L.; Shau, H.; Turcillo, P.; Moldawer, N.; Golub, S.; deKemion, J.; Figlin, R. Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma. J. Urol. 150:1384-1390; 1993.
6. Rosenberg, S. A. Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer. J. Clin. Oncol. 10:180-199; 1992.
7. Whittington, R.; Faulds, D. Interleukin 2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446-514; 1993.
8. Rosenberg, S. A.; Yang, J. C.; Topalian, S. L.; Schwartzentruber, D. J.; Weber, J. S.; Parkinson, D. R.; Seipp, C. A.; Einhorn, J. H.; White, D. E. Treatment of 283 consecutive patients with meta-static melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271:907-913; 1994.
9. Sahin, U.; Türeci, O.; Schmitt, H.; Cochlovius, B.; Johannes, T.; Schmits, R.; Stenner, F.; Luo, G.; Schobert, J.; Pfreundschuh, M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92:11810-11813; 1995.
10. Gaugler, B.; Brouwenstijn, N.; Vantomme, V.; Szikora, J. P.; Van der Spek, C. W.; Patard, J. J.; Boon, T.; Schrier, P.; Van den Eynde, B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics 44:323-330; 1996.
11. Oosterwijk, E.; Ruiter, D. J.; Hocdemaeker, P. J.; Pauwels, E. K.; Jonas, U.; Zwartendijk, J.; Warnaar, S. O. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer 38:489-494; 1986.
12. Liang, P.; Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-972; 1992.
13. Peters, J.-M. Proteasomes: Protein degradation machines of the cell. Trends Biochem. Sci. 19:377-382; 1994.
14. Tsumuri, C.; Shimizu, Y.; Saeki, M.; Kato, S.; Demartino, G. N.; Slaughter, C. A.; Fujimuro, M.; Yokosawa, H.; Yamasaki, M.; Hendil, K, B.; Toh-e, A.; Tanahashi, N.; Tanaka, K. cDNA cloning and functional analysis of the p97 subunit of the 26 S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11. Eur. J. Biochem. 239:912-921; 1996.
15. Dunbar, J. D.; Song, H. Y.; Guo, D.; Wu, L.-W.; Donner, D. B. Two-hybrid cloning of a gene encoding TNF receptor-associated protein-2, a protein that interacts with the intracellular domain of the type 1 TNF receptor. J. Immunol. 158:4252-4259; 1997.
16. Tsumuri, C.; Demartino, G. N.; Slaughter, C. A.; Shimbara, N.; Tanaka, K. cDNA cloning of a regulatory subunit of the human 26S proteasome, a homolog of Mov-34 gene product. Biochem. Biophys. Res. Commun. 210:600-608; 1995.
17. Yokota, K.; Kagawa, S.; Shimizu, Y.; Akioka, H.; Tsumuri, C.; Noda, C.; Fujimuro, M.; Yokosawa, H.; Fujiwara, T.; Takahashi, E.; Ohba, M.; Yamasaki, M.; Demartino, G. N.; Slaughter, C. A.; Toh-e, A.; Tanaka, K. Molecular cloning of cDNA encoding a largest regulatory subunit p112 of the human 26S proteasome and functional analysis of its homolog Sen3p in budding yeast. Mol. Biol. Cell 7:853-870; 1996.
18. Beck, S.; Abdulla, S.; Alderton, R. P.; Glynne, R. J.; Gut, I. G.; Hosking, L. K.; Jackson, A.; Kelly, A.; Newell, W. R.; Sanseau, P.; Radley, E.; Thorpe, K. I.; Trowsdale, J. Evolutionary dynamics of non-coding sequences, sequences within the class II region of the human MHC. J. Mol. Biol. 255:1-13; 1995.
19. Johnsen, A.; France, J.; Sy, M.-S.; Harding, C. V. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res. 58:3660-3667; 1998.
20. Boldin, M. P.; Mett, I. L.; Wallach, D. A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain.' FEBS Lett. 363: 39-44; 1995.
21. Palombella, V. J.; Rando, O. J.; Goldberg, A. L.; Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773-785; 1995.
22. Rock, K. L.; Gramm, C.; Rothstein, L.; Clark, K.; Stein, R.; Dick, L.; Hwang, D.; Goldberg, A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771; 1994.
23. Heemels, M. T.; Ploegh, H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-491; 1995.
24. Seliger, B.; Harders, C.; Lohrmann, S.; Momburg, F.; Urlinger, S.; Tampé, R.; Huber, C. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts. Eur. J. Immunol. 28:122-133; 1998.
25. Hampton, R. Y.; Gardner, R. G.; Rine, J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7:2029-2044; 1996.